/Sponsor / Executive Profile

James N. Topper, M.D., Ph.D.

Executive

Aggregate Capital Deployment Matrix

Professional Biography

James N. Topper, M.D., Ph.D., serves as our Chief Executive Officer and Chairman of our board of directors.

Total Capital Deployed

$100,000,000

Active / Searching Capital:
-

Transaction Volume

2 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • Biotechnology1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
NAMS
NewAmsterdam Pharma Company N.V.
announced
-
$10.00
-Dec 2022-
391.0M
General
FLAC
Frazier Lifesciences Acquisition Corporation
closed
100.0M
$10.00
1/3Nov 2020Done-BiotechnologyCredit Suisse Securities (USA) LLC